Clinical Trial Update: Mol Epi GrAS in Nicaragua

View source ↗

Summary

The Mol Epi GrAS trial in Nicaragua sponsored by NIAID was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcal Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Streptococcus Group A | Status: TERMINATED